Not only does pulmonary hypertension appear to be associated with reduced PPARγ expression, emerging evidence suggests that ligand-induced PPARγ activation attenuates pulmonary vasculardysfunction in animal models of pulmonary hypertension. This evidence concerns the gene PPARG and pulmonary hypertension.